These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects. Vandongen R; Davidson L; Beilin LJ; Barden AE Br J Clin Pharmacol; 1981 Sep; 12(3):369-74. PubMed ID: 6271155 [TBL] [Abstract][Full Text] [Related]
9. Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers. Walden RJ; Tomlinson B; Graham B; Smith C; Betteridge DJ; Prichard BN Br J Clin Pharmacol; 1990 Oct; 30(4):547-56. PubMed ID: 1981317 [TBL] [Abstract][Full Text] [Related]
10. The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects. Kiyingi KS; Shaw J Eur J Clin Pharmacol; 1984; 27(4):423-8. PubMed ID: 6097455 [TBL] [Abstract][Full Text] [Related]
11. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. Antonaccio MJ; High J; DeForrest JM; Sybertz E J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238 [TBL] [Abstract][Full Text] [Related]
13. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal. Rangno RE; Langlois S; Stewart J Clin Pharmacol Ther; 1982 May; 31(5):564-71. PubMed ID: 7075106 [TBL] [Abstract][Full Text] [Related]
14. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity". Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise. Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity. Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824 [TBL] [Abstract][Full Text] [Related]
17. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity. Daul A; Wang XL; Borchard U; Bock KD; Brodde OE J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860 [TBL] [Abstract][Full Text] [Related]
19. Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol. Giudicelli Y; Lacasa D; Agli B; Leneveu A Eur J Clin Pharmacol; 1984; 26(1):7-12. PubMed ID: 6325205 [TBL] [Abstract][Full Text] [Related]